Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes may also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Insulin, a hormone medication used to regulate blood sugar, has long been one of the most important therapies for managing type 2 diabetes. But with the rise of semaglutide (Ozempic) and other ...

The European Association for the Study of Diabetes and the American Diabetes Association have updated their joint guidance on T2D management.

For people with Type 2 diabetes, following at least six healthy lifestyle habits when taking GLP-1 RA medications can lower their risk of heart attack, stroke, hospital visits due to cardiovascular ...

Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

Dr. Lily Chao, Director of the Type 2 Diabetes Clinic at Children's Hospital Los Angeles outlines two new studies that illuminate how GLP-1s could enhance care for youth-onset Type 2 diabetes.

The type 2 diabetes market is expected to witness steady growth, driven by the rising global prevalence of diabetes, increasing rates of obesity and sedentary lifestyles, and growing awareness of ...